Bookedited by Melanie A. Simpson, Paraskevi Heldin.
Contents:
Ch. 1. Emerging roles for hyaluronidase in cancer metastasis and therapy
Ch. 2. Targeting hyaluronic acid family for cancer chemoprevention and therapy
Ch. 3. Aberrant posttranscriptional processing of hyaluronan synthase 1 in malignant transformation and tumor progression
Ch. 4. Hyaluronan synthases posttranslational regulation in cancer
Ch.4. Hyaluronan synthases posttranslational regulation in cancer
Ch. 5. Hyaluronan-coated extraellular vesicles, a novel link between hyaluronan and cancer
Ch.6.Hyaluronan in the healthy and malignant hematopoietic microenvironment
Ch. 7. Hyaluronan regulation of endothelial barrier function in cancer
Ch. 8. HAS2 and CD44 in breast tumorigenesis
Ch. 9. CD44 is a multidomain signaling platform that integrates extracellular matrix cues with growth factor and cytokine signals
Ch. 10. Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression
Ch. 11. Advances and advantages of nanomedicine in the pharmacological targeting of hyaluronan-CD44 interactions and signaling in cancer
Ch.12. Hyaluronan/RHAMM interactions in mesenchymal tumor pathogenesis: role of growth factors
Ch. 13. CD147: regulator of hyaluronan signaling in invasiveness and chemoresistance
Index.